States Current Economic Recession Seems to Be Only Factor Restraining Growth.
Jun. 22, 2009 (U.S. Equity News) -- HepaLife
Technologies, Inc. (OTCBB: HPLF) announced today that a newly issued
...
HepaLife Technologies, Inc. (OTCBB:HPLF) (FWB:HL1) (WKN:500625), today
announced that the Company will present new data from ongoing research
and development of its...
HepaLife expands team with addition of regulatory expert; Company
continues development of first-of-its-kind bioartificial liver device
following positive research...
BOSTON--(BUSINESS WIRE)--HepaLife Technologies, Inc. (OTCBB:HPLF) (FWB:HL1) (WKN:500625) today announced that the Company’s patented “PBS-1” cells, under development...
BOSTON--(BUSINESS WIRE)--HepaLife Technologies, Inc. (OTCBB:HPLF) (FWB:HL1) (WKN:500625) today announced the appointment of Mr. Javier Jimenez, a seasoned, senior medical device and...
BOSTON--(BUSINESS WIRE)--HepaLife Technologies, Inc. (OTCBB:HPLF) (FWB:HL1) (WKN:500625) today announced the appointment of Stem Cell Systems GmbH (Germany) among plans to accelerate...
BOSTON--(BUSINESS WIRE)--HepaLife Technologies, Inc. (OTCBB:HPLF) (FWB:HL1) (WKN:500625) today announced the appointment of Stem Cell Systems GmbH (Germany) among plans to accelerate...
BOSTON--(BUSINESS WIRE)--HepaLife Technologies, Inc. (OTCBB:HPLF) (FWB:HL1) (WKN:500625) today
announced that the Company’s patented ‘PBS-1’
cells, under development...
BOSTON--(BUSINESS WIRE)--HepaLife Technologies, Inc. (OTCBB: HPLF) (FWB: HL1) (WKN: 500625) is
pleased to announce the addition of Dr. Robert C. Tuttle to the Company’s ...
BOSTON--(BUSINESS WIRE)--HepaLife Technologies, Inc. (OTCBB: HPLF) (FWB: HL1) (WKN: 500625) today
announced plans to expand its influenza vaccine development initiative
following...
BOSTON--(BUSINESS WIRE)--HepaLife Technologies, Inc. (OTCBB: HPLF) (FWB: HL1) (WKN: 500625) today
announced confirmation that the Company’s
patented ‘PBS-1’ ...
BOSTON--(BUSINESS WIRE)--HepaLife Technologies, Inc. (OTCBB:HPLF) (FWB:HL1) (WKN:500625) today
announced that a US Government report issued last week by the Department
of Health and...
BOSTON--(BUSINESS WIRE)--HepaLife Technologies Inc. (OTCBB: HPLF) (FWB: HL1), today announced the
appointment of Mr. Frank Menzler as its President, Chief Executive
Officer, and a...
#16: HPLF News Dr. Paul Coussens Joins HepaLife's Scientific Advisory Board; Wild Birds Now Nesting in Alaska and Canada Will Begin Their Migration South This Fall
BOSTON--(BUSINESS WIRE)--Aug. 15, 2006-- Monitoring of Migratory Birds to Prevent a Deadly Bird Flu Virus Now is in Effect for the Entire Nation HepaLife Technologies Inc. (OTCBB:...